Remember how that Google neural net learned to tell the difference between dogs and cats? It's helping catch skin cancer now, thanks to some scientists at Stanford who trained it up and then loosed it ...
In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...
Skin cancer is the most common form of cancer -- 1 in 5 Americans will develop it in their lifetime – but it’s curable when caught early. A new device powered by artificial intelligence is helping ...
DERM is an artificial intelligence (AI)-based skin lesion analysis technology intended for use in the screening, triage and assessment of suspected skin cancer lesions in people aged 18 or over. DERM ...
The purpose of this assessment is to assess the clinical and cost effectiveness of the VivaScope 1500 and 3000 imaging systems to: help decide whether to biopsy and excise skin lesions in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback